Live Oak Health Sciences FundLOGSX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$49.5M
Expense ratio
1.04%
1-year return
+14.1%
3 years, a year
+7.3%
5 years, a year
+5.8%
Holdings
29
What it aims to do.
The Fund seeks long-term capital growth.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| UTHR United Therapeutics Corp | 6.40% |
| CAH Cardinal Health Inc | 5.57% |
| JAZZ Jazz Pharmaceuticals Plc | 5.25% |
| NVS Novartis Ag | 5.01% |
| COR Cencora Inc | 5.00% |
| AMGN Amgen Inc | 4.95% |
| Mount Vernon Liquid Assets Portfolio, LLC | 4.90% |
| MCK Mckesson Corp | 4.90% |
| EXEL Exelixis Inc | 4.71% |
| REGN Regeneron Pharmaceuticals Inc | 4.66% |
More on LOGSX.
- LOGSX overview
- LOGSX holdings
- LOGSX risk
- LOGSX costs
- LOGSX money in and out
- LOGSX share classes
- Compare LOGSX with other funds
Returns after fees, from the fund's SEC filings up to Apr 2026. Past returns are not a promise. Not financial advice.